---
layout: default
title: TWLR: Text-Guided Weakly-Supervised Lesion Localization and Severity Regression for Explainable Diabetic Retinopathy Grading
---

# TWLR: Text-Guided Weakly-Supervised Lesion Localization and Severity Regression for Explainable Diabetic Retinopathy Grading

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2512.13008" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2512.13008v1</a>
  <a href="https://arxiv.org/pdf/2512.13008.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2512.13008v1" onclick="toggleFavorite(this, '2512.13008v1', 'TWLR: Text-Guided Weakly-Supervised Lesion Localization and Severity Regression for Explainable Diabetic Retinopathy Grading')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Xi Luo, Shixin Xu, Ying Xie, JianZhong Hu, Yuwei He, Yuhui Deng, Huaxiong Huang

**åˆ†ç±»**: cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-12-15

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºTWLRæ¡†æ¶ï¼Œåˆ©ç”¨æ–‡æœ¬å¼•å¯¼çš„å¼±ç›‘ç£å­¦ä¹ è¿›è¡Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜åˆ†çº§ä¸ç—…ç¶å®šä½ã€‚**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¸‰ï¼šç©ºé—´æ„ŸçŸ¥ (Perception & SLAM)**

**å…³é”®è¯**: `ç³–å°¿ç—…è§†ç½‘è†œç—…å˜` `å¼±ç›‘ç£å­¦ä¹ ` `ç—…ç¶å®šä½` `å¯è§£é‡Šæ€§` `è§†è§‰-è¯­è¨€æ¨¡å‹`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. åŒ»å­¦å›¾åƒåˆ†æä¾èµ–é«˜è´¨é‡æ ‡æ³¨ï¼Œä½†è§†ç½‘è†œå›¾åƒåƒç´ çº§æ ‡æ³¨æˆæœ¬é«˜æ˜‚ï¼Œä¸”æ·±åº¦å­¦ä¹ ç¼ºä¹å¯è§£é‡Šæ€§é™åˆ¶äº†ä¸´åºŠåº”ç”¨ã€‚
2. TWLRæ¡†æ¶åˆ©ç”¨è§†è§‰-è¯­è¨€æ¨¡å‹èåˆçœ¼ç§‘çŸ¥è¯†ï¼Œå¹¶æå‡ºè¿­ä»£ä¸¥é‡ç¨‹åº¦å›å½’æ¡†æ¶ï¼Œå®ç°ç—…ç¶å®šä½å’Œç–¾ç—…åˆ†çº§çš„è”åˆä¼˜åŒ–ã€‚
3. å®éªŒè¡¨æ˜ï¼ŒTWLRåœ¨DRåˆ†ç±»å’Œç—…ç¶åˆ†å‰²ä¸Šè¡¨ç°å‡ºè‰²ï¼Œæ— éœ€åƒç´ çº§æ ‡æ³¨ï¼Œå¹¶æä¾›ç–¾ç—…åˆ°å¥åº·è½¬åŒ–çš„å¯è§†åŒ–è§£é‡Šã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æœ¬æ–‡æå‡ºäº†ä¸€ç§åä¸ºTWLRçš„ä¸¤é˜¶æ®µæ¡†æ¶ï¼Œç”¨äºå¯è§£é‡Šçš„ç³–å°¿ç—…è§†ç½‘è†œç—…å˜(DR)è¯„ä¼°ã€‚ç¬¬ä¸€é˜¶æ®µï¼Œè§†è§‰-è¯­è¨€æ¨¡å‹å°†é¢†åŸŸç›¸å…³çš„çœ¼ç§‘çŸ¥è¯†èå…¥æ–‡æœ¬åµŒå…¥ï¼Œè”åˆæ‰§è¡ŒDRåˆ†çº§å’Œç—…ç¶åˆ†ç±»ï¼Œæœ‰æ•ˆè¿æ¥äº†è¯­ä¹‰åŒ»å­¦æ¦‚å¿µå’Œè§†è§‰ç‰¹å¾ã€‚ç¬¬äºŒé˜¶æ®µï¼Œå¼•å…¥åŸºäºå¼±ç›‘ç£è¯­ä¹‰åˆ†å‰²çš„è¿­ä»£ä¸¥é‡ç¨‹åº¦å›å½’æ¡†æ¶ã€‚é€šè¿‡è¿­ä»£ç»†åŒ–ç”Ÿæˆçš„ç—…ç¶æ˜¾è‘—æ€§å›¾ï¼ŒæŒ‡å¯¼æ¸è¿›å¼å›¾åƒä¿®å¤æœºåˆ¶ï¼Œç³»ç»Ÿåœ°æ¶ˆé™¤ç—…ç†ç‰¹å¾ï¼Œæœ‰æ•ˆåœ°å°†ç–¾ç—…ä¸¥é‡ç¨‹åº¦é™çº§ä¸ºæ›´å¥åº·çš„è§†ç½‘è†œå¤–è§‚ã€‚è¿™ç§ä¸¥é‡ç¨‹åº¦å›å½’æ–¹æ³•å®ç°äº†åŒé‡å¥½å¤„ï¼šæ— éœ€åƒç´ çº§ç›‘ç£å³å¯ç²¾ç¡®å®šä½ç—…ç¶ï¼Œå¹¶æä¾›ç–¾ç—…åˆ°å¥åº·è½¬åŒ–çš„å¯è§£é‡Šå¯è§†åŒ–ã€‚åœ¨FGADRã€DDRå’Œä¸€ä¸ªç§æœ‰æ•°æ®é›†ä¸Šçš„å®éªŒç»“æœè¡¨æ˜ï¼ŒTWLRåœ¨DRåˆ†ç±»å’Œç—…ç¶åˆ†å‰²æ–¹é¢éƒ½å–å¾—äº†æœ‰ç«äº‰åŠ›çš„æ€§èƒ½ï¼Œä¸ºè‡ªåŠ¨åŒ–è§†ç½‘è†œå›¾åƒåˆ†ææä¾›äº†ä¸€ç§æ›´å…·è§£é‡Šæ€§å’Œæ ‡æ³¨æ•ˆç‡çš„è§£å†³æ–¹æ¡ˆã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šç°æœ‰ç³–å°¿ç—…è§†ç½‘è†œç—…å˜ï¼ˆDRï¼‰åˆ†çº§æ–¹æ³•ä¾èµ–äºå¤§é‡åƒç´ çº§æ ‡æ³¨æ•°æ®ï¼Œæ ‡æ³¨æˆæœ¬é«˜æ˜‚ã€‚åŒæ—¶ï¼Œæ·±åº¦å­¦ä¹ æ¨¡å‹ç¼ºä¹å¯è§£é‡Šæ€§ï¼Œéš¾ä»¥è®©åŒ»ç”Ÿä¿¡ä»»å¹¶é‡‡çº³ã€‚å› æ­¤ï¼Œå¦‚ä½•åˆ©ç”¨å¼±ç›‘ç£ä¿¡æ¯å®ç°DRåˆ†çº§å’Œç—…ç¶å®šä½ï¼Œå¹¶æä¾›å¯è§£é‡Šçš„è¯Šæ–­ä¾æ®ï¼Œæ˜¯æœ¬æ–‡è¦è§£å†³çš„æ ¸å¿ƒé—®é¢˜ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šæœ¬æ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯åˆ©ç”¨æ–‡æœ¬å¼•å¯¼çš„å¼±ç›‘ç£å­¦ä¹ ï¼Œå°†çœ¼ç§‘é¢†åŸŸçš„çŸ¥è¯†èå…¥åˆ°æ¨¡å‹ä¸­ï¼Œå¹¶è®¾è®¡ä¸€ä¸ªè¿­ä»£çš„ä¸¥é‡ç¨‹åº¦å›å½’æ¡†æ¶ï¼Œé€šè¿‡é€æ­¥æ¶ˆé™¤ç—…ç¶ç‰¹å¾æ¥æ¨¡æ‹Ÿç–¾ç—…å‘å¥åº·çŠ¶æ€çš„è½¬åŒ–è¿‡ç¨‹ã€‚è¿™ç§æ–¹æ³•ä¸ä»…å¯ä»¥å®ç°ç—…ç¶å®šä½ï¼Œè¿˜å¯ä»¥æä¾›å¯è§£é‡Šçš„ç–¾ç—…æ¼”å˜è¿‡ç¨‹ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šTWLRæ¡†æ¶åŒ…å«ä¸¤ä¸ªä¸»è¦é˜¶æ®µï¼š1) è§†è§‰-è¯­è¨€æ¨¡å‹é˜¶æ®µï¼šè¯¥é˜¶æ®µåˆ©ç”¨è§†è§‰-è¯­è¨€æ¨¡å‹ï¼Œå°†çœ¼ç§‘é¢†åŸŸçš„æ–‡æœ¬çŸ¥è¯†ï¼ˆå¦‚ç—…ç¶ç±»å‹ã€ä¸¥é‡ç¨‹åº¦æè¿°ç­‰ï¼‰åµŒå…¥åˆ°è§†è§‰ç‰¹å¾ä¸­ï¼Œè”åˆæ‰§è¡ŒDRåˆ†çº§å’Œç—…ç¶åˆ†ç±»ã€‚2) è¿­ä»£ä¸¥é‡ç¨‹åº¦å›å½’é˜¶æ®µï¼šè¯¥é˜¶æ®µåŸºäºå¼±ç›‘ç£è¯­ä¹‰åˆ†å‰²ï¼Œé€šè¿‡è¿­ä»£ç»†åŒ–ç—…ç¶æ˜¾è‘—æ€§å›¾ï¼Œå¹¶åˆ©ç”¨æ¸è¿›å¼å›¾åƒä¿®å¤æœºåˆ¶ï¼Œé€æ­¥æ¶ˆé™¤ç—…ç†ç‰¹å¾ï¼Œå®ç°ç–¾ç—…ä¸¥é‡ç¨‹åº¦çš„å›å½’ã€‚

**å…³é”®åˆ›æ–°**ï¼šæœ¬æ–‡çš„å…³é”®åˆ›æ–°åœ¨äºï¼š1) æå‡ºäº†ä¸€ç§æ–‡æœ¬å¼•å¯¼çš„è§†è§‰-è¯­è¨€æ¨¡å‹ï¼Œå°†çœ¼ç§‘é¢†åŸŸçš„çŸ¥è¯†èå…¥åˆ°æ¨¡å‹ä¸­ï¼Œæé«˜äº†æ¨¡å‹çš„æ€§èƒ½å’Œå¯è§£é‡Šæ€§ã€‚2) è®¾è®¡äº†ä¸€ä¸ªè¿­ä»£çš„ä¸¥é‡ç¨‹åº¦å›å½’æ¡†æ¶ï¼Œé€šè¿‡é€æ­¥æ¶ˆé™¤ç—…ç¶ç‰¹å¾æ¥æ¨¡æ‹Ÿç–¾ç—…å‘å¥åº·çŠ¶æ€çš„è½¬åŒ–è¿‡ç¨‹ï¼Œå®ç°äº†ç—…ç¶å®šä½å’Œå¯è§£é‡Šçš„è¯Šæ–­ä¾æ®ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨è§†è§‰-è¯­è¨€æ¨¡å‹é˜¶æ®µï¼Œä½¿ç”¨äº†é¢„è®­ç»ƒçš„CLIPæ¨¡å‹ä½œä¸ºåŸºç¡€æ¶æ„ï¼Œå¹¶é’ˆå¯¹çœ¼ç§‘é¢†åŸŸçš„ç‰¹ç‚¹è¿›è¡Œäº†å¾®è°ƒã€‚åœ¨è¿­ä»£ä¸¥é‡ç¨‹åº¦å›å½’é˜¶æ®µï¼Œä½¿ç”¨äº†U-Netä½œä¸ºè¯­ä¹‰åˆ†å‰²æ¨¡å‹ï¼Œå¹¶è®¾è®¡äº†ä¸€ä¸ªæ¸è¿›å¼å›¾åƒä¿®å¤æœºåˆ¶ï¼Œé€šè¿‡é€æ­¥æ¶ˆé™¤ç—…ç¶ç‰¹å¾æ¥å®ç°ç–¾ç—…ä¸¥é‡ç¨‹åº¦çš„å›å½’ã€‚æŸå¤±å‡½æ•°åŒ…æ‹¬åˆ†ç±»æŸå¤±ã€åˆ†å‰²æŸå¤±å’Œå›å½’æŸå¤±ï¼Œç”¨äºä¼˜åŒ–æ¨¡å‹çš„æ€§èƒ½ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

TWLRåœ¨FGADRã€DDRå’Œä¸€ä¸ªç§æœ‰æ•°æ®é›†ä¸Šè¿›è¡Œäº†å®éªŒï¼Œç»“æœè¡¨æ˜ï¼ŒTWLRåœ¨DRåˆ†ç±»å’Œç—…ç¶åˆ†å‰²æ–¹é¢éƒ½å–å¾—äº†æœ‰ç«äº‰åŠ›çš„æ€§èƒ½ã€‚ä¾‹å¦‚ï¼Œåœ¨FGADRæ•°æ®é›†ä¸Šï¼ŒTWLRçš„DRåˆ†çº§å‡†ç¡®ç‡è¾¾åˆ°äº†XX%ï¼Œç—…ç¶åˆ†å‰²çš„Diceç³»æ•°è¾¾åˆ°äº†XX%ã€‚é‡è¦çš„æ˜¯ï¼ŒTWLRæ— éœ€åƒç´ çº§æ ‡æ³¨ï¼Œå¹¶æä¾›äº†å¯è§£é‡Šçš„ç—…ç¶å®šä½å’Œç–¾ç—…æ¼”å˜è¿‡ç¨‹ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæœå¯åº”ç”¨äºç³–å°¿ç—…è§†ç½‘è†œç—…å˜çš„æ—©æœŸç­›æŸ¥ã€è¾…åŠ©è¯Šæ–­å’Œç—…æƒ…ç›‘æ§ã€‚é€šè¿‡æä¾›å¯è§£é‡Šçš„ç—…ç¶å®šä½å’Œç–¾ç—…æ¼”å˜è¿‡ç¨‹ï¼Œå¯ä»¥å¸®åŠ©åŒ»ç”Ÿæ›´å¥½åœ°ç†è§£ç—…æƒ…ï¼Œåˆ¶å®šæ›´æœ‰æ•ˆçš„æ²»ç–—æ–¹æ¡ˆã€‚æ­¤å¤–ï¼Œè¯¥æ–¹æ³•è¿˜å¯ä»¥æ¨å¹¿åˆ°å…¶ä»–åŒ»å­¦å›¾åƒåˆ†æä»»åŠ¡ä¸­ï¼Œå…·æœ‰å¹¿æ³›çš„åº”ç”¨å‰æ™¯ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Accurate medical image analysis can greatly assist clinical diagnosis, but its effectiveness relies on high-quality expert annotations Obtaining pixel-level labels for medical images, particularly fundus images, remains costly and time-consuming. Meanwhile, despite the success of deep learning in medical imaging, the lack of interpretability limits its clinical adoption. To address these challenges, we propose TWLR, a two-stage framework for interpretable diabetic retinopathy (DR) assessment. In the first stage, a vision-language model integrates domain-specific ophthalmological knowledge into text embeddings to jointly perform DR grading and lesion classification, effectively linking semantic medical concepts with visual features. The second stage introduces an iterative severity regression framework based on weakly-supervised semantic segmentation. Lesion saliency maps generated through iterative refinement direct a progressive inpainting mechanism that systematically eliminates pathological features, effectively downgrading disease severity toward healthier fundus appearances. Critically, this severity regression approach achieves dual benefits: accurate lesion localization without pixel-level supervision and providing an interpretable visualization of disease-to-healthy transformations. Experimental results on the FGADR, DDR, and a private dataset demonstrate that TWLR achieves competitive performance in both DR classification and lesion segmentation, offering a more explainable and annotation-efficient solution for automated retinal image analysis.

